Go Pro
NASDAQ:DFNS

Nukkleus (DFNS) Stock Price, News & Analysis

Nukkleus logo
$12.19 0.00 (0.00%)
As of 08/28/2026 04:00 PM Eastern

About Nukkleus Stock (NASDAQ:DFNS)

Advanced

Key Stats

Today's Range
$11.90
$12.58
50-Day Range
$3.90
$84.98
52-Week Range
$3.70
$1,948.75
Volume
577,571 shs
Average Volume
2.23 million shs
Market Capitalization
$12.31 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Moderate Buy

Company Overview

Nukkleus Inc., a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions. Nukkleus Inc. was founded in 2013 and is headquartered in Jersey City, New Jersey.

Nukkleus Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
24th Percentile Overall Score

DFNS MarketRank™: 

Nukkleus scored higher than 24% of companies evaluated by MarketBeat, and ranked 579th out of 671 stocks in the industrials sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Nukkleus has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 strong buy rating, no buy ratings, no hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Nukkleus has only been the subject of 2 research reports in the past 90 days.

  • Read more about Nukkleus' stock forecast and price target.
  • Earnings Growth

    Earnings for Nukkleus are expected to decrease in the coming year, from ($3.90) to ($5.09) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Nukkleus is -0.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Nukkleus is -0.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Percentage of Shares Shorted

    16.11% of the float of Nukkleus has been sold short.
  • Short Interest Ratio / Days to Cover

    Nukkleus has a short interest ratio ("days to cover") of 0.06, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Nukkleus has recently decreased by 48.23%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Nukkleus does not currently pay a dividend.

  • Dividend Growth

    Nukkleus does not have a long track record of dividend growth.

  • News Sentiment

    Nukkleus has a news sentiment score of 0.59. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.85 average news sentiment score of Industrials companies.
  • News Coverage This Week

    MarketBeat has tracked 13 news articles for Nukkleus this week, compared to 3 articles on an average week.
  • Search Interest

    Only 20 people have searched for DFNS on MarketBeat in the last 30 days. This is a decrease of -26% compared to the previous 30 days.
  • MarketBeat Follows

    5 people have added Nukkleus to their MarketBeat watchlist in the last 30 days. This is an increase of 400% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Nukkleus insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    11.14% of the stock of Nukkleus is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    12.47% of the stock of Nukkleus is held by institutions.

  • Read more about Nukkleus' insider trading history.
Receive DFNS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nukkleus and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

DFNS Stock News Headlines

Nukkleus (NASDAQ:DFNS) & VirTra (NASDAQ:VTSI) Critical Analysis
What is Noble Financial's Forecast for Nukkleus Q3 Earnings?
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Trump has issued emergency support to accelerate the rollout, and it's already live in multiple states. The Financial Times reports Sam Altman is personally calling people to build this for OpenAI. A few little-known companies control the entire supply chain - meaning anyone who wants access must go through them. Their stocks are available to buy right now.tc pixel
Wall Street Zen Upgrades Nukkleus (NASDAQ:DFNS) to Sell
See More Headlines

DFNS Stock Analysis - Frequently Asked Questions

Nukkleus' stock was trading at $503.75 on January 1st, 2026. Since then, DFNS stock has decreased by 97.6% and is now trading at $12.19.

Nukkleus Inc. (NASDAQ:DFNS) announced its earnings results on Wednesday, August, 19th. The company reported ($173.80) EPS for the quarter, missing the consensus estimate of ($3.11) by $170.69. The company had revenue of $4 million for the quarter, compared to analysts' expectations of $4.50 million.

Nukkleus shares reverse split on Thursday, October 24th 2024.The 1-8 reverse split was announced on Friday, October 18th 2024. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, October 23rd 2024. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split.

Shares of DFNS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Nukkleus investors own include Lithium Americas (LAC), Meta Platforms (META), Advanced Micro Devices (AMD), iSpecimen (ISPC), NVIDIA (NVDA) and Applied Materials (AMAT).

Company Calendar

Last Earnings
8/19/2026
Today
8/30/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Aerospace & Defense
Sub-Industry
Aerospace & Defense
Current Symbol
NASDAQ:DFNS
Previous Symbol
NASDAQ:NUKK
CIK
1787518
Fax
N/A
Employees
12
Year Founded
2013

Profitability

EPS (Trailing Twelve Months)
($397.10)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$78.55 million
Net Margins
N/A
Pretax Margin
-1,854.62%
Return on Equity
-190.60%
Return on Assets
-26.92%

Debt

Debt-to-Equity Ratio
0.07
Current Ratio
0.14
Quick Ratio
0.11

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
$406.33 per share
Price / Cash Flow
0.03
Book Value
($90.93) per share
Price / Book
-0.13

Miscellaneous

Outstanding Shares
1,010,000
Free Float
1,479,000
Market Cap
$12.31 million
Optionable
N/A
Beta
-5.80

Social Links

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

This page (NASDAQ:DFNS) was last updated on 8/31/2026 by MarketBeat.com Staff.
From Our Partners